Back to Search Start Over

Potential anti-adhesion activity of novel carbosilane zwitterionic dendrimers against eukaryotic and prokaryotic pathogenic microorganisms.

Authors :
Gómez-Casanova, Natalia
Martín-Serrano Ortiz, Ángela
Heredero-Bermejo, Irene
Sánchez-Nieves, Javier
Luis Copa-Patiño, José
Javier de la Mata, F.
Source :
European Journal of Pharmaceutics & Biopharmaceutics. Oct2023, Vol. 191, p158-165. 8p.
Publication Year :
2023

Abstract

[Display omitted] The development of biofilms on different surfaces continues to be a major public health problem. The antimicrobial resistance and the difficulty of finding drugs capable of combating these established biofilms generates the urgent need to find compounds that prevent cells from settling and establishing of these complex communities of microorganisms. Zwitterionic modification of nanomaterials allows the formation of a hydration layer, and this highly hydrophilic surface provides antifouling properties as well as a good biocompatibility by preventing non-specific interactions. Thus, they are appropriate candidates to prevent microbial adhesion to different surfaces and, in consequence, avoid biofilm formation. For this reason, we have incorporated zwitterionic moieties in multivalent systems, as are carbosilane dendrimers. Characterization of these systems was performed using nuclear magnetic resonance and mass spectrometry. It has been analysed if the new molecules have capacity to inhibit the biofilm formation in Candida albicans, Staphylococcus aureus and Pseudomonas aeruginosa. The results showed that they were more effective against S. aureus, observing a biofilm reduction of 81.5% treating with 32 mg/L of G2SiZWsf dendrimer and by 72.5% using 32 mg/L of the G3SiZWsf dendrimer. Finally, the absence of cytotoxicity was verified by haemolysis and cytotoxicity studies in human cells lines. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
09396411
Volume :
191
Database :
Academic Search Index
Journal :
European Journal of Pharmaceutics & Biopharmaceutics
Publication Type :
Academic Journal
Accession number :
172366204
Full Text :
https://doi.org/10.1016/j.ejpb.2023.07.021